Glucose-Solofarm Polyflac Domus, 5% 200 ml

Hepatitis, Poisoning, Dizziness, Liver damage, Hypoglycemia, Bleeding, Weakness and fatigue, Fainting

• hypoglycemia;
• .carbohydrate malnutrition;
• toxicinfection;
• intoxication in liver diseases (hepatitis, dystrophy and atrophy of the liver, including.ч. liver failure);
• hemorrhagic diathesis;
• dehydration (vomiting, diarrhea, postoperative period);
• intoxication;
• collapse;
• shock.

.

Indications

hypoglycemia;
carbohydrate deficiency;
toxic infection;
intoxication due to liver diseases (hepatitis, liver dystrophy and atrophy, including liver failure);
hemorrhagic diathesis;
dehydration (vomiting, diarrhea, postoperative period);
intoxication;
collapse;
shock.

Pharmacological effect

Participates in various metabolic processes in the body.

Special instructions

Control of water and electrolyte balance.

To increase osmolarity, a 5% solution can be combined with isotonic sodium chloride solution.

For more complete and rapid absorption of glucose administered in large doses, simultaneously with it you can administer 4-5 units of short-acting insulin subcutaneously, at the rate of 1 unit of insulin per 4-5 g of glucose.

For patients with diabetes mellitus, glucose is administered under the control of its content in the blood and urine.

Impact on the ability to drive vehicles and operate machinery

No negative effects on the ability to drive vehicles and operate machinery have been identified.

Active ingredient

Dextrose

Composition

1 ml dextrose 0.05 g

Excipients:

Contraindications

hyperglycemia;
hyperlactic acidemia;
overhydration;
postoperative disturbances in glucose utilization;
circulatory disorders that threaten cerebral and pulmonary edema;
cerebral edema;
pulmonary edema;
acute left ventricular failure;
hyperosmolar coma;
children’s age (for solutions over 20-25%);
hypersensitivity.

With caution: decompensated chronic heart failure, chronic renal failure (oligo-, anuria), hyponatremia, diabetes mellitus.

Side Effects

Hypervolemia, acute left ventricular failure; if the rate of administration is exceeded – osmotic diuresis with loss of water, electrolytes and the development of hyperosmolar coma.

Interaction

When combined with other drugs, it is necessary to monitor pharmaceutical compatibility, incl. visually.

Overdose

Symptoms: hyperglycemia, glycosuria, hyperglycemic, hyperosmolar coma, hyperhydration, water-electrolyte imbalance, increased liponeogenesis with increased production of CO2, which leads to a sharp increase in minute tidal volume and, as a consequence, respiratory rate, fatty infiltration of the liver.

Treatment: stop glucose administration, introduce short-acting insulin, symptomatic therapy.

Storage conditions

At temperatures from 5 to 30°C. Keep out of the reach of children.

Shelf life

3 years

Manufacturer

Grotex LLC, Russia